The Current Ratio as of December 2025 (TTM) for Abbott India Limited (ABBOTINDIA.BO) is 2.75

According to Abbott India Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.75. This represents a change of 79.43% compared to the average of 1.54 of the last 4 quarters.

Abbott India Limited (ABBOTINDIA.BO) Historical Current Ratio (quarterly & annually)

How has ABBOTINDIA.BO Current Ratio performed in the past?

The mean historical Current Ratio of Abbott India Limited over the last ten years is 3.19. The current 2.75 Current Ratio has changed 8.53% with respect to the historical average. Over the past ten years (40 quarters), ABBOTINDIA.BO's Current Ratio was at its highest in in the March 2016 quarter at 3.79. The Current Ratio was at its lowest in in the December 2015 quarter at 0.

Abbott India Limited (ABBOTINDIA.BO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Abbott India Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abbott India Limited (ABBOTINDIA.BO) Average Current Ratio

How has ABBOTINDIA.BO Current Ratio performed in the past?

The current Current Ratio of Abbott India Limited (ABBOTINDIA.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Abbott India Limited (ABBOTINDIA.BO) Current Ratio vs. Peers

How is ABBOTINDIA.BO’s Current Ratio compared to its peers?

Abbott India Limited’s Current Ratio is greater than Alkem Laboratories Limited (2.49), greater than Alkem Laboratories Limited (2.49), greater than GlaxoSmithKline Pharmaceuticals Limited (1.78), greater than GlaxoSmithKline Pharmaceuticals Limited (1.78), greater than Aurobindo Pharma Limited (1.85), greater than Aurobindo Pharma Limited (1.85), greater than Glenmark Pharmaceuticals Limited (0), greater than Glenmark Pharmaceuticals Limited (0), less than Gland Pharma Limited (4.13), greater than Laurus Labs Limited (1.32),

Build a custom stock screener for Abbott India Limited (ABBOTINDIA.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abbott India Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abbott India Limited (ABBOTINDIA.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abbott India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.